Logos Global Management LP Dyne Therapeutics, Inc. Transaction History

Logos Global Management LP

$513 Million
Q1 2025

A detailed history of Logos Global Management LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 500,000 shares of DYN stock, worth $5.24 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

500,000

Previous 450,000 11.11%

Holding current value

$5.24 Million

Previous $10.6 Million 50.67%

% of portfolio

1.02%

Previous 1.39%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$10.46 - $25.46 $523,000 - $1.27 Million	50,000 Added 11.11%	500,000 $5.23 Million
Q4 2024 Feb 14, 2025	BUY	$23.56 - $35.55 $6.83 Million - $10.3 Million	290,000 Added 181.25%	450,000 $10.6 Million
Q3 2024 Nov 14, 2024	SELL	$31.94 - $47.04 $3.35 Million - $4.94 Million	-105,000 Reduced 39.62%	160,000 $5.75 Million
Q2 2024 Aug 14, 2024	SELL	$23.65 - $35.63 $34.6 Million - $52.2 Million	-1,465,000 Reduced 84.68%	265,000 $9.35 Million
Q1 2024 May 15, 2024	SELL	$13.06 - $29.18 $1.96 Million - $4.38 Million	-150,000 Reduced 7.98%	1,730,000 $49.1 Million
Q4 2023 Feb 14, 2024	SELL	$6.62 - $13.64 $1.99 Million - $4.09 Million	-300,000 Reduced 13.76%	1,880,000 $25 Million
Q3 2023 Nov 14, 2023	BUY	$8.6 - $12.18 $3.44 Million - $4.87 Million	400,000 Added 22.47%	2,180,000 $19.5 Million
Q2 2023 Aug 14, 2023	BUY	$8.53 - $14.28 $682,400 - $1.14 Million	80,000 Added 4.71%	1,780,000 $20 Million
Q1 2023 May 15, 2023	SELL	$10.88 - $15.0 $4.9 Million - $6.75 Million	-450,000 Reduced 20.93%	1,700,000 $19.6 Million
Q4 2022 Feb 14, 2023	SELL	$9.37 - $13.8 $1.29 Million - $1.9 Million	-137,321 Reduced 6.0%	2,150,000 $24.9 Million
Q3 2022 Nov 14, 2022	SELL	$7.2 - $15.17 $4.41 Million - $9.29 Million	-612,679 Reduced 21.13%	2,287,321 $29 Million
Q2 2022 Aug 15, 2022	BUY	$4.36 - $10.5 $722,050 - $1.74 Million	165,608 Added 6.06%	2,900,000 $19.9 Million
Q1 2022 May 16, 2022	SELL	$6.52 - $12.27 $3.26 Million - $6.14 Million	-500,000 Reduced 15.46%	2,734,392 $26.4 Million
Q4 2021 Feb 14, 2022	SELL	$11.89 - $16.07 $4.58 Million - $6.19 Million	-385,000 Reduced 10.64%	3,234,392 $38.5 Million
Q3 2021 Nov 15, 2021	BUY	$15.6 - $21.46 $24.4 Million - $33.6 Million	1,565,000 Added 76.18%	3,619,392 $58.8 Million
Q2 2021 Aug 16, 2021	SELL	$15.94 - $22.33 $18.3 Million - $25.7 Million	-1,150,000 Reduced 35.89%	2,054,392 $43.2 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $22.4 Million - $46.9 Million	1,600,000 Added 99.73%	3,204,392 $49.8 Million
Q3 2020 Nov 17, 2020	BUY	$20.0 - $23.9 $16.1 Million - $19.2 Million	804,392 Added 100.55%	1,604,392 $32.4 Million
Q3 2020 Nov 16, 2020	BUY	$20.0 - $23.9 $16 Million - $19.1 Million	800,000 New	800,000 $16.2 Million

Others Institutions Holding DYN

# of Institutions

218

Shares Held

116M

Call Options Held

322K

Put Options Held

66.2K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $542M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Account

Logos Global Management LP Dyne Therapeutics, Inc. Transaction History